Latest Supply Chain Challenges News

EcoGraf has appointed Sven Olsson as an independent director and Peter Schuhmacher as a board advisor to bolster its European investor relations and advance its HFfree purification technology amid growing ESG demand.

The a2 Milk Company faced significant supply chain disruptions in its China infant formula segment during late FY26, causing a 14% sales decline in that category. Despite this, overall revenue rose 12% on FY25, supported by strong performances in other product lines and improved margins.

James Hardie Industries releases its 2026 AGM materials, highlighting a $4.8 billion sales year boosted by AZEK acquisition, board renewals, and a revamped executive pay structure.

Australian Rare Earths (ASX: AR3) has announced a maiden Ore Reserve of 26 million tonnes at 920 ppm TREO for its Koppamurra Rare Earths Project, underpinned by a robust Pre-Feasibility Study delivering an A$858 million post-tax NPV and a rapid payback of less than one year.

The a2 Milk Company has announced a $300 million fully franked special dividend following regulatory clearance in China to rebrand infant formula products under its a2 label.

Lithium Universe (ASX: LU7) has demonstrated near-complete recovery of gold and copper from electronic waste using a novel, low-temperature hydrometallurgical process developed by the University of Edinburgh. This breakthrough supports its push into sustainable metal recycling and lithium supply chain projects.

Lakes Blue Energy reports promising pressure build-up and confirms extensive gas-bearing sands at Wombat-5, targeting enhanced perforation and flow testing in late August 2026.

Synlait Milk is on track to refinance its senior bank facilities by June 30, 2026, replacing a $130 million shareholder loan from Bright Dairy with a new two-year loan. The company reported a preliminary net loss of $12 million for the first four months of 2026, reflecting operational headwinds and the recent North Island asset sale.

Boresight Ltd (ASX: BST) is seeking to raise $8 million through a public offer to expand its cost-effective military drone manufacturing, targeting growth in the US and European markets.

The a2 Milk Company (ASX:A2M) has denied any undisclosed material information following a sharp share price drop and increased trading volumes, attributing market moves to a recent analyst downgrade citing supply chain uncertainties.

a2 Milk confirms no undisclosed information behind recent share price moves, attributing volatility to a CLSA downgrade citing supply delays and previously disclosed risks.

Austco Healthcare expects FY26 revenue between A$90 million and A$95 million, driven by strong sales and a significant US rollout. Net profit after tax is forecast to jump over 50%, supported by operational growth and a one-off benefit.